Annual report
6197.TEDINET S100OP3R
Period2021-04-01 → 2022-03-31
Filed2022-07-11
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100OHXH. Amended by S100OP3W (2022-07-11).
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥117.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥106.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥95.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥84.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥74.3bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥6.3bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥6.1bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥6.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.1bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.4bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.0bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.2bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.6bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥5.4bn | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.7bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥3.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥70.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥60.1bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥57.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥45.8bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥37.7bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥50.6bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥41.6bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.5bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥16.8bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥13.9bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥11.9bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.0bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.2bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.8bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.7bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.1bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥7.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.8bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.0bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥37.08 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.51 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.33 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.5 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.53 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥37.02 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.41 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.12 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.1 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.75 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥212.96 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥195.51 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥177.7 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥148 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥127.15 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 28.5% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.4% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.5% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 18.1% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.1% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 27.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.5% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 30,928 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 29,838 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 27,174 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 25,996 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 25,318 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥91.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥82.3bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥77.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥73.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥70.2bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥4.8bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥4.7bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.8bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.7bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.4bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.1bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥4.1bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.9bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥2.9bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥4.3bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥3.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.8bn | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥61.6bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥52.0bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥50.0bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥38.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥35.1bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥43.4bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥34.8bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.3bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥17.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥16.1bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥12.0bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.7bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥30.25 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.69 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.65 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.51 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.35 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.2 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.62 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥45.47 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.15 | 2018-04-01 → 2019-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.55 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.5 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥192.9 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥182.17 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥170.95 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥145.9 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥129.04 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 29.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.3% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.1% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 28.8% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.3% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.8% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 94,579,550 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,437,900 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,325,700 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,125,600 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,116,900 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 24,890 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 24,286 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 24,118 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 23,806 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 23,732 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 74
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥26m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥14m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 105 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥516m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥516m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥352m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥365m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥239m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥9.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥4.6bn |
| Medical Support Servicesreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥112m |
| Medical Support Servicesreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥50m |
| Medical Support Servicesreportable segment | employees | at 2022-03-31 | 20612 pure |
| Medical Support Servicesreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥66.0bn |
| Medical Support Servicesreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥66.0bn |
| Medical Support Servicesreportable segment | segment assets | at 2022-03-31 | ¥9.6bn |
| Medical Support Servicesreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥8.4bn |
| Nursing Care And Child Care Servicesreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥9.7bn |
| Nursing Care And Child Care Servicesreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥892m |
| Nursing Care And Child Care Servicesreportable segment | employees | at 2022-03-31 | 9993 pure |
| Nursing Care And Child Care Servicesreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥50.7bn |
| Nursing Care And Child Care Servicesreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥50.7bn |
| Nursing Care And Child Care Servicesreportable segment | segment assets | at 2022-03-31 | ¥51.0bn |
| Nursing Care And Child Care Servicesreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.8bn |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥9.8bn |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥943m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥116.7bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥116.7bn |
| —segment total | segment assets | at 2022-03-31 | ¥60.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥9.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥957m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥117.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥117.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥60.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥10.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-04-01 → 2021-03-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-04-01 → 2021-03-31 | ¥524m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥524m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-03-31 | ¥118m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2021-03-31 | ¥44m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥386m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥154m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥10.0bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥4.0bn |
| Medical Support Servicesreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥108m |
| Medical Support Servicesreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥47m |
| Medical Support Servicesreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥60.9bn |
| Medical Support Servicesreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥60.9bn |
| Medical Support Servicesreportable segment | segment assets | at 2021-03-31 | ¥8.0bn |
| Medical Support Servicesreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥7.7bn |
| Nursing Care And Child Care Servicesreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥5.5bn |
| Nursing Care And Child Care Servicesreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥837m |
| Nursing Care And Child Care Servicesreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥44.7bn |
| Nursing Care And Child Care Servicesreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥44.7bn |
| Nursing Care And Child Care Servicesreportable segment | segment assets | at 2021-03-31 | ¥42.0bn |
| Nursing Care And Child Care Servicesreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥2.3bn |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥885m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥105.7bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥105.7bn |
| —segment total | segment assets | at 2021-03-31 | ¥50.0bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥10.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥898m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥106.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥106.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥50.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥10.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 100 pure |
| Medical Support Servicesreportable segment | employees | at 2022-03-31 | 20612 pure |
| Nursing Care And Child Care Servicesreportable segment | employees | at 2022-03-31 | 3960 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,484
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding guarantee obligations (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities increased or decreased as result of acquisition or disposal of business or merger etc whereby cash was paid or received as consideration (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |